CITALOR 40 MG COM REV CT BL AL/AL X 30
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1883000880093 -
GGREM
541522040025317 -
Código de barras
7908236800995
O que a fonte publica
- Detentor do registro
- VIATRIS FARMACEUTICA DO BRASIL LTDA
- Princípios ativos
- ATORVASTATINA CÁLCICA
- Embalagem
- 40 MG COM REV CT BL AL/AL X 30
- Regime de dispensação
- Tarja Vermelha
- Tipo de produto
- Novo
- Classe terapêutica
- C10A1 - ESTATINAS, INIBIDORES DA REDUTASE HMG-CoA
- Prescrição
- Sob prescrição ou restrito
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "CITALOR 40 MG COM REV CT BL AL/AL X 30",
"holder": "VIATRIS FARMACEUTICA DO BRASIL LTDA",
"stripe": "Tarja Vermelha",
"barcodes": [
"7908236800995"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "541522040025317",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "11.643.096/0001-22",
"priceRegime": "Regulado",
"productName": "CITALOR",
"productType": "Novo",
"hospitalOnly": false,
"presentation": "40 MG COM REV CT BL AL/AL X 30",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha",
"factoryPrices": {
"icms-0": "198.96",
"icms-12": "226.09",
"icms-17": "239.71",
"icms-18": "242.63",
"icms-19": "245.63",
"icms-20": "248.70",
"icms-21": "251.85",
"icms-22": "255.08",
"icms-23": "258.39",
"icms-17.5": "241.16",
"icms-19.5": "247.16",
"icms-20.5": "250.26",
"icms-22.5": "256.72",
"icms-12-alc": "223.38",
"icms-17-alc": "236.83",
"icms-18-alc": "239.72",
"icms-19-alc": "242.68",
"icms-20-alc": "245.72",
"icms-21-alc": "248.83",
"icms-22-alc": "252.02",
"icms-23-alc": "255.29",
"withoutTaxes": "196.57",
"icms-17.5-alc": "238.27",
"icms-19.5-alc": "244.19",
"icms-20.5-alc": "247.26",
"icms-22.5-alc": "253.64"
},
"pisCofinsList": "Positiva",
"substanceText": "ATORVASTATINA CÁLCICA",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "274.25",
"icms-12": "311.64",
"icms-17": "330.42",
"icms-18": "334.44",
"icms-19": "338.58",
"icms-20": "342.81",
"icms-21": "347.15",
"icms-22": "351.60",
"icms-23": "356.16",
"icms-17.5": "332.41",
"icms-19.5": "340.68",
"icms-20.5": "344.96",
"icms-22.5": "353.86",
"icms-12-alc": "308.81",
"icms-17-alc": "327.40",
"icms-18-alc": "331.40",
"icms-19-alc": "335.49",
"icms-20-alc": "339.69",
"icms-21-alc": "343.99",
"icms-22-alc": "348.40",
"icms-23-alc": "352.92",
"withoutTaxes": "271.75",
"icms-17.5-alc": "329.39",
"icms-19.5-alc": "337.58",
"icms-20.5-alc": "341.82",
"icms-22.5-alc": "350.64"
},
"invalidBarcodes": [],
"activeSubstances": [
"ATORVASTATINA CÁLCICA"
],
"therapeuticClass": "C10A1 - ESTATINAS, INIBIDORES DA REDUTASE HMG-CoA",
"commercialisation": {
"year": 2025,
"marketed": true
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1883000880093",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "C10A1",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:541522040025317"